Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacovigilance in practice].

A Spreux1, B Baldin, R M Chichmanian

  • 1Centre régional de pharmacovigilance et d'information sur le médicament, CHU de Nice, hôpital Pasteur, France.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|September 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Odderon Exchange from Elastic Scattering Differences between pp and pp[over ¯] Data at 1.96 TeV and from pp Forward Scattering Measurements.

Physical review letters·2021
Same author

Fatal cholestatic hepatitis after a single dose of celecoxib.

Clinics and research in hepatology and gastroenterology·2018
Same author

Constraints on Sub-GeV Dark-Matter-Electron Scattering from the DarkSide-50 Experiment.

Physical review letters·2018
Same author

Low-Mass Dark Matter Search with the DarkSide-50 Experiment.

Physical review letters·2018
Same author

Measurement of the Effective Weak Mixing Angle in pp[over ¯]→Z/γ^{*}→ℓ^{+}ℓ^{-} Events.

Physical review letters·2018
Same author

[Uveitis treated with biotherapy and/or DMARD: Analysis from the French Pharmacovigilance Study Base].

Journal francais d'ophtalmologie·2018
Same journal

Albumin priming enables safe and effective red blood cell exchange in low-weight children with sickle cell disease.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to rescue the harvests.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver Transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

TLR4/MD-2 complex promotes transfusion-related acute lung injury pathogenesis through the activation of the AP-1 and NF-κB signaling pathways.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

The Strategic Utility of Cryopreserved Platelets in Outer Space.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Genotyping of Human Neutrophil Antigen-3 by High Resolution Melting Analysis in Southern Thai Blood Donors.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
See all related articles

The French pharmacovigilance system monitors drugs post-authorization, involving health professionals and pharmaceutical companies. This system ensures drug safety through data analysis and information dissemination, cooperating with European agencies.

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Public Health Surveillance
  • Pharmaceutical Regulation

Context:

  • The French pharmacovigilance system, directed by the French Agency for the Safety of Health Products (AFSSAPS), oversees approximately 3,700 pharmaceutical products.
  • These products include treatments, preventatives, diagnostics, and drugs modifying physiological functions, all requiring official marketing authorizations (AMM or ATU).

Purpose:

  • To detail the structure and operation of the French pharmacovigilance system.
  • To outline the roles of key stakeholders, including AFSSAPS, Regional Centers of Pharmacovigilance, health professionals, and pharmaceutical laboratories.
  • To highlight the mechanisms for reporting adverse drug reactions and ensuring post-authorization drug safety.

Summary:

  • The system mandates health professionals to report suspected serious or unexpected adverse effects promptly.

Related Experiment Videos

  • Data from a national report bank is analyzed for drug safety alerts and inquiries.
  • Regional centers provide crucial drug information services.

    • Impact:

    • Enhances post-marketing drug surveillance and patient safety in France.
    • Facilitates rapid identification and management of potential drug-related risks.
    • Contributes to the broader European network for medicinal product evaluation and safety.